Amorphous Solid Dispersions
Visualize, optimize, and de-risk spray-dried dispersions. We link SDD microstructure to dissolution, stability, manufacturability, and tech transfer.
Who this is for
Built for teams developing and scaling SDDs, HMEs, and other amorphous solid dispersion products.
Typical use cases:
- Formulation scientists evaluating SDD feasibility and formulation trade-offs
- Drug product and CMC teams defining CQAs, CPPs, and control strategies for tablets, capsules, granules, and DPIs
- Tech transfer leaders comparing internal sites and external CDMO partners
- Program leaders reducing dissolution, manufacturability, and bioavailability risk in late-stage development
Why SDDs fail
The critical signals are usually hidden in the particle microstructure.
Spray-dried dispersions can form hollow, porous, shell-like, or internally heterogeneous particles that strongly affect dissolution, stability, tabletability, yield, and ultimately clinical performance.
Most conventional tools do not quantify these structures, or do not have the right sensitivity. Teams usually see the consequences only later: failed dissolution tests, tablet defects, site-to-site differences, transfer issues, and unexpected bioavailability outcomes.
Business Outcomes
SDD Microstructure Solution in 4 tiers
A defined 3 to 6 week engagment that combines 3D X-ray micro CT imaging and advanced AI analytics to:
What You Get
Inform your SDDs with microstructure intelligence
Contact a product specialist for the right level of support for your needs
